Citadel Advisors - ADMA BIOLOGICS INC ownership

ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 75 filers reported holding ADMA BIOLOGICS INC in Q4 2019. The put-call ratio across all filers is 2.88 and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ADMA BIOLOGICS INC
ValueSharesWeighting
Q3 2023$3,157,356
+536.8%
881,943
+556.4%
0.00%
Q2 2023$495,785
-55.7%
134,359
-60.2%
0.00%
Q1 2023$1,118,105
-29.5%
337,796
-17.4%
0.00%
Q4 2022$1,585,834
+17.6%
408,720
-26.3%
0.00%
Q3 2022$1,349,000
+80.8%
554,857
+47.2%
0.00%
Q2 2022$746,000
-5.4%
376,927
-12.5%
0.00%
Q1 2022$789,000
-32.2%
430,646
-47.8%
0.00%
Q4 2021$1,164,000
+125.6%
825,149
+80.8%
0.00%
Q3 2021$516,000
-28.9%
456,388
+0.5%
0.00%
Q2 2021$726,000
-28.4%
454,115
-21.1%
0.00%
Q1 2021$1,014,000
+11.7%
575,662
+23.6%
0.00%
Q4 2020$908,000
+33.5%
465,879
+63.9%
0.00%
Q3 2020$680,000
-24.7%
284,300
-7.7%
0.00%
Q2 2020$903,000
+146.7%
308,167
+142.5%
0.00%
Q1 2020$366,000
+26.2%
127,079
+75.0%
0.00%
Q4 2019$290,000
-16.2%
72,607
-6.8%
0.00%
Q3 2019$346,000
+302.3%
77,911
+251.2%
0.00%
Q2 2019$86,000
+100.0%
22,187
+96.3%
0.00%
Q1 2019$43,000
-27.1%
11,300
-12.3%
0.00%
Q1 2018$59,00012,8900.00%
Other shareholders
ADMA BIOLOGICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Velan Capital Investment Management LP 4,000,000$15,520,00013.71%
Stonepine Capital Management, LLC 6,940,000$26,927,20011.33%
Caligan Partners LP 2,676,093$10,383,2418.64%
Altium Capital Management LP 2,870,000$11,135,6005.66%
AWM Investment Company, Inc. 6,015,000$23,338,2003.36%
EAM Investors, LLC 1,749,598$6,788,4401.40%
Perceptive Advisors 11,900,255$46,172,9891.30%
EAM Global Investors LLC 836,323$3,244,9330.84%
Potomac Capital Management, Inc. 120,000$4660.54%
OBERWEIS ASSET MANAGEMENT INC/ 536,900$2,083,1720.44%
View complete list of ADMA BIOLOGICS INC shareholders